dehydroepiandrosterone has been researched along with ADDH in 10 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study aimed to investigate serum cortisol, dehydroepiandrosterone (DHEA), and oxytocin levels of children with attention-deficit/hyperactivity disorder (ADHD) combined presentation and those diagnosed with ADHD combined presentation and coexisting conduct disorder." | 7.88 | Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder. ( Bilgiç, A; Işık, Ü; Kılınç, I; Toker, A, 2018) |
| "The present study aimed to investigate serum cortisol, dehydroepiandrosterone (DHEA), and oxytocin levels of children with attention-deficit/hyperactivity disorder (ADHD) combined presentation and those diagnosed with ADHD combined presentation and coexisting conduct disorder." | 3.88 | Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder. ( Bilgiç, A; Işık, Ü; Kılınç, I; Toker, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, LJ | 4 |
| Chan, WC | 1 |
| Chou, MC | 1 |
| Chou, WJ | 1 |
| Lee, MJ | 1 |
| Lee, SY | 2 |
| Lin, PY | 1 |
| Yang, YH | 1 |
| Yen, CF | 1 |
| Işık, Ü | 1 |
| Bilgiç, A | 1 |
| Toker, A | 1 |
| Kılınç, I | 1 |
| Molina-Carballo, A | 1 |
| Justicia-Martínez, F | 1 |
| Moreno-Madrid, F | 1 |
| Cubero-Millán, I | 1 |
| Machado-Casas, I | 1 |
| Moreno-García, L | 1 |
| León, J | 1 |
| Luna-Del-Castillo, JD | 1 |
| Uberos, J | 1 |
| Muñoz-Hoyos, A | 1 |
| Wu, CC | 3 |
| Tsai, YF | 1 |
| Ko, HJ | 1 |
| Kim, I | 1 |
| Kim, JB | 1 |
| Moon, Y | 1 |
| Whang, MC | 1 |
| Lee, KM | 1 |
| Jung, SP | 1 |
| Huang, YS | 2 |
| Hsiao, CC | 2 |
| Chiang, YL | 2 |
| Shang, ZY | 2 |
| Chen, CK | 2 |
| Ree, SC | 1 |
| Chen, YC | 1 |
| Wu, YW | 1 |
| Trent, S | 1 |
| Dean, R | 1 |
| Veit, B | 1 |
| Cassano, T | 1 |
| Bedse, G | 1 |
| Ojarikre, OA | 1 |
| Humby, T | 1 |
| Davies, W | 1 |
| Maayan, R | 2 |
| Yoran-Hegesh, R | 2 |
| Strous, R | 1 |
| Nechmad, A | 1 |
| Averbuch, E | 2 |
| Weizman, A | 2 |
| Spivak, B | 2 |
| Strous, RD | 1 |
| Kotler, M | 1 |
| Mester, R | 1 |
5 trials available for dehydroepiandrosterone and ADDH
| Article | Year |
|---|---|
Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.
Topics: Administration, Oral; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; | 2014 |
Effects of Korean red ginseng extract on behavior in children with symptoms of inattention and hyperactivity/impulsivity: a double-blind randomized placebo-controlled trial.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dehydroepiandrosterone; Double-Bli | 2014 |
Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.
Topics: Affective Symptoms; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Ch | 2011 |
Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dehydroepia | 2003 |
Analysis of neurosteroid levels in attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Dehydroepiandrosterone; Dehydroepi | 2001 |
5 other studies available for dehydroepiandrosterone and ADDH
| Article | Year |
|---|---|
Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.
Topics: Attention Deficit Disorder with Hyperactivity; Biomarkers; Child; Dehydroepiandrosterone; Female; Ge | 2017 |
Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Conduct Disorder; Dehydroepiandros | 2018 |
Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Biomarkers; Central Nervous Sy | 2014 |
Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Cross-Sectional Studies; Dehydroepiandrosteron | 2011 |
Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder.
Topics: Acetylserotonin O-Methyltransferase; Animals; Appetitive Behavior; Attention Deficit Disorder with H | 2013 |